Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-29

Clinical Trial Update: Oxybutynin for Post-surgical Bladder Pain and Urgency [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating oxybutynin for post-surgical bladder pain and urgency is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • oxybutynin (oxybutynin)

Snippet

Sponsor: University of California, Davis | Conditions: Overactive Bladder Syndrome, Neuropathic Bladder | Phase 3 | Status: RECRUITING